Jeffrey Bryant

Jeffrey Bryant is a Senior Scientist in Discovery at Arcellx since April 2023, bringing extensive experience in molecular biology and virology from previous roles at Oncorus, where positions included Senior Scientist and Scientist from March 2019 to March 2023. Prior experience includes a postdoctoral research position at Duke University's Department of Neurosurgery, focusing on the immunotherapeutic effects of recombinant poliovirus in cancer treatment, and a Ph.D. research role at Duke, investigating translation regulation and oncolytic poliovirus interactions with chemotherapy. Jeffrey Bryant has also served as a teaching assistant for various undergraduate and graduate courses while earning a Ph.D. in Molecular Genetics and Microbiology and holds a Bachelor of Science in Microbiology and Chemistry from Kansas State University.